Federation Des Caisses Desjardins Du Quebec Capricor Therapeutics, Inc. Transaction History
Federation Des Caisses Desjardins Du Quebec
- $18.9 Billion
- Q3 2024
A detailed history of Federation Des Caisses Desjardins Du Quebec transactions in Capricor Therapeutics, Inc. stock. As of the latest transaction made, Federation Des Caisses Desjardins Du Quebec holds 2,058 shares of CAPR stock, worth $29,079. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,058
Previous 1,932
6.52%
Holding current value
$29,079
Previous $9,000
244.44%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding CAPR
# of Institutions
92Shares Held
8.13MCall Options Held
1.78MPut Options Held
1.4M-
Black Rock Inc. New York, NY1.63MShares$23 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.58MShares$22.3 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA638KShares$9.02 Million0.0% of portfolio
-
State Street Corp Boston, MA512KShares$7.24 Million0.0% of portfolio
-
Superstring Capital Management LP New York, NY337KShares$4.77 Million4.49% of portfolio
About CAPRICOR THERAPEUTICS, INC.
- Ticker CAPR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,346,200
- Market Cap $344M
- Description
- Capricor Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the development of transformative cell and exosome-based therapeutics for the treatment and prevention of spectrum of diseases and disorders. Its lead candidate, CAP-1002, an allogeneic cardiac-derived cell therapy, which has completed phase III clinical trial for th...